awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42139529-16CAE7FB-F761-4147-8E1E-7CC7194D8CA5
Q42139529-16CAE7FB-F761-4147-8E1E-7CC7194D8CA5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42139529-16CAE7FB-F761-4147-8E1E-7CC7194D8CA5
Therapeutic efficacy of SYM004, a mixture of two anti-EGFR antibodies in human colorectal cancer with acquired resistance to cetuximab and MET activation.
P2860
Q42139529-16CAE7FB-F761-4147-8E1E-7CC7194D8CA5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42139529-16CAE7FB-F761-4147-8E1E-7CC7194D8CA5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
024549fa2b96872d4c791c8de4bf80c934941a6f
P2860
Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study